Logo image of MDAI

SPECTRAL AI INC (MDAI) Stock Fundamental Analysis

NASDAQ:MDAI - Nasdaq - US84757T1051 - Common Stock - Currency: USD

2.68  +0.15 (+5.93%)

After market: 2.73 +0.05 (+1.87%)

Fundamental Rating

1

Taking everything into account, MDAI scores 1 out of 10 in our fundamental rating. MDAI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of MDAI have multiple concerns. MDAI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MDAI had negative earnings in the past year.
In the past year MDAI has reported a negative cash flow from operations.
In the past 5 years MDAI reported 4 times negative net income.
MDAI had a negative operating cash flow in each of the past 5 years.
MDAI Yearly Net Income VS EBIT VS OCF VS FCFMDAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

MDAI's Return On Assets of -44.46% is on the low side compared to the rest of the industry. MDAI is outperformed by 65.24% of its industry peers.
Industry RankSector Rank
ROA -44.46%
ROE N/A
ROIC N/A
ROA(3y)-41.51%
ROA(5y)-25.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDAI Yearly ROA, ROE, ROICMDAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

MDAI's Gross Margin of 45.05% is on the low side compared to the rest of the industry. MDAI is outperformed by 61.50% of its industry peers.
MDAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MDAI Yearly Profit, Operating, Gross MarginsMDAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

MDAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MDAI has more shares outstanding
The debt/assets ratio for MDAI is higher compared to a year ago.
MDAI Yearly Shares OutstandingMDAI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
MDAI Yearly Total Debt VS Total AssetsMDAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -0.40, we must say that MDAI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.40, MDAI is not doing good in the industry: 60.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.4
ROIC/WACCN/A
WACC8.69%
MDAI Yearly LT Debt VS Equity VS FCFMDAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

MDAI has a Current Ratio of 1.41. This is a normal value and indicates that MDAI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.41, MDAI is doing worse than 79.14% of the companies in the same industry.
A Quick Ratio of 1.37 indicates that MDAI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.37, MDAI is doing worse than 64.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.37
MDAI Yearly Current Assets VS Current LiabilitesMDAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

MDAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.56%, which is quite impressive.
The Revenue has grown by 99.04% in the past year. This is a very strong growth!
EPS 1Y (TTM)64.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.33%
Revenue 1Y (TTM)99.04%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.02%

3.2 Future

MDAI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.14% yearly.
The Revenue is expected to grow by 10.53% on average over the next years. This is quite good.
EPS Next Y82.6%
EPS Next 2Y18.02%
EPS Next 3Y7.11%
EPS Next 5Y19.14%
Revenue Next Year-23.53%
Revenue Next 2Y-6.16%
Revenue Next 3Y2.88%
Revenue Next 5Y10.53%

3.3 Evolution

MDAI Yearly Revenue VS EstimatesMDAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
MDAI Yearly EPS VS EstimatesMDAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 -0.5 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDAI. In the last year negative earnings were reported.
Also next year MDAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDAI Price Earnings VS Forward Price EarningsMDAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDAI Per share dataMDAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.02%
EPS Next 3Y7.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MDAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPECTRAL AI INC

NASDAQ:MDAI (7/3/2025, 1:57:40 PM)

After market: 2.73 +0.05 (+1.87%)

2.68

+0.15 (+5.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)N/A N/A
Inst Owners10.37%
Inst Owner Change5.54%
Ins Owners29.93%
Ins Owner Change2.69%
Market Cap69.01M
Analysts84
Price Target4.89 (82.46%)
Short Float %4.72%
Short Ratio2.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)17.12%
Min Revenue beat(2)8.99%
Max Revenue beat(2)25.25%
Revenue beat(4)4
Avg Revenue beat(4)15.07%
Min Revenue beat(4)8.99%
Max Revenue beat(4)25.25%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.01%
PT rev (3m)-6.45%
EPS NQ rev (1m)18.52%
EPS NQ rev (3m)40.54%
EPS NY rev (1m)65.71%
EPS NY rev (3m)74.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)14.26%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-12.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.3
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS1.16
BVpS-0.06
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.05%
FCFM N/A
ROA(3y)-41.51%
ROA(5y)-25.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.37
Altman-Z -0.4
F-Score5
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.33%
EPS Next Y82.6%
EPS Next 2Y18.02%
EPS Next 3Y7.11%
EPS Next 5Y19.14%
Revenue 1Y (TTM)99.04%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.02%
Revenue Next Year-23.53%
Revenue Next 2Y-6.16%
Revenue Next 3Y2.88%
Revenue Next 5Y10.53%
EBIT growth 1Y50.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year51.4%
EBIT Next 3Y46.05%
EBIT Next 5Y19.67%
FCF growth 1Y-735.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-735.83%
OCF growth 3YN/A
OCF growth 5YN/A